<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01050673</url>
  </required_header>
  <id_info>
    <org_study_id>CE/030/VJT</org_study_id>
    <nct_id>NCT01050673</nct_id>
  </id_info>
  <brief_title>Trial of Versajet Compared With Conventional Treatment in Acute and Chronic Wounds</brief_title>
  <official_title>A Study to Investigate the Time to Closure of Delayed Healing Dehisced Incisions, Delayed Healing Traumatic Wounds or Chronic Cutaneous Defects Surgically Excised With VERSAJET Compared Conventional Operating Room Techniques</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Smith &amp; Nephew, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Smith &amp; Nephew, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is increasingly recognised that the debridement of devitalised, bacterially contaminated
      or senescent tissue is an essential component of the effective treatment of delayed healing
      wounds.

      Whilst surgical debridement procedures have conventionally been performed with scalpels and
      other sharp instrumentation, alternative techniques such as the VERSAJET Hydrosurgery System
      are becoming more widespread.

      To increase the adoption of this new technology, it is essential that clinical improvements
      are assessed alongside the potential impact on the costs of debridement and the net financial
      impact on the hospital.

      It is hypothesised that a decrease in the time to achieve stable wound closure will not only
      lead to a patient benefit, but also a potential reduction in the cost of treatment due to
      e.g. repeat procedures, longer hospital stay, infection etc. The purpose of this study is to
      investigate the difference in time to closure of wounds surgically excised with VERSAJET
      Hydrosurgery System and those surgically excised using conventional operating room
      techniques.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is increasingly recognised that the debridement of devitalised, bacterially contaminated
      or senescent tissue is an essential component of the effective treatment of delayed healing
      wounds. Whilst passive autolytic or enzymatic debridement procedures have their place, where
      patients are unable to tolerate any surgical procedure, the judicious use of surgical
      debridement to rapidly remove necrotic, contaminated tissue and slough has been shown to
      offer many advantages in returning a wound to a healing trajectory.

      Whilst surgical debridement procedures have conventionally been performed with scalpels and
      other sharp instrumentation, alternative techniques such as the VERSAJET Hydrosurgery System
      are becoming more widespread.

      To increase the adoption of this new technology, it is essential that clinical improvements
      are assessed alongside the potential impact on the costs of debridement and the net financial
      impact on the hospital. In fiscal year 2004, there were more than 57,000 discharges under DRG
      code 217 ('wound debridement and skin graft except hand) in the United States. Mean length of
      stay (all payers) was 11 days and mean charges were $52,800. In 2005, Medicare funded 15,800
      discharges under this code. Average charges for these patients were $56,500 and average
      reimbursement was $18,2654. In this context it is particularly important that the potential
      patient benefit and cost impact of new technology is fully assessed.

      It is hypothesised that a decrease in the time to achieve stable wound closure will not only
      lead to a patient benefit, but also a potential reduction in the cost of treatment due to
      e.g. repeat procedures, longer hospital stay, infection etc. The purpose of this study is to
      investigate the difference in time to closure of wounds surgically excised with VERSAJET
      Hydrosurgery System and those surgically excised using conventional operating room
      techniques.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in Time to Closure Between Wounds Surgically Excised With VERSAJET™ Hydrosurgery System and Those Surgically Excised Using Conventional Operating Room Techniques.</measure>
    <time_frame>28 days plus 6 week follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time of Actual Excision Procedure</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost Per Operative Procedure</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of Reference Wound-related Surgical Procedures to Achieve Closure</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative Bacteriology From Standardised Tissue Biopsies Pre- /Post- 1st Excision &amp; Pre-closure</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Patients Achieving Stable Closure Within Study Period</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay (1st Excision to Discharge (Days))</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patient's With Wound-related Readmissions</measure>
    <time_frame>28 days and 6 week follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patient's With Serious Adverse Events and Relationship to Device</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Surgical Wound Dehiscence</condition>
  <arm_group>
    <arm_group_label>VERSAJET</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Excision with VERSAJET™ Hydrosurgery System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional operating room excision will consist of sharp instrumentation and electrocautery techniques, with the use of pulse lavage at the investigator's discretion. The type of sharp instrumentation, together with the brand of pulse lavage will be recorded.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VERSAJET</intervention_name>
    <description>Hydro-surgery debridement</description>
    <arm_group_label>VERSAJET</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Scalpel or blade</intervention_name>
    <description>Conventional Surgical Debridement</description>
    <arm_group_label>Conventional Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 18 years and older

          -  Male, and female patients (provided they are not pregnant and if of reproductive age
             are using contraception)

          -  Patients with a delayed healing traumatic wound or chronic cutaneous defect of 30 days
             or more in duration, or a delayed healing dehisced incision that requires excision to
             remove necrotic or infected tissue

          -  Patients who are deemed to require closure by primary intention or definitive cover
             with an autologous split-thickness skin graft (STSG) or flap

          -  Patients who are hospital in-patients, or will be an in-patient for the period of 1st
             excision to closure

          -  Patients deemed suitable for debridement with both VERSAJET Hydrosurgery System and
             conventional operating room techniques

          -  Patients undergoing surgical excision of their reference wound in the operating room
             (OR)

          -  Patients able to understand the evaluation and willing to consent to the evaluation

        Exclusion Criteria:

          -  Patients who have previously undergone surgical excision of the reference wound by the
             Principal Investigator in the last 30 days

          -  Patients with coagulopathy (including those with haemophilia)

          -  Patients with vasculitis, non-reconstructive peripheral vascular disease, pyoderma
             granulosa, renal failure or lymphoedema

          -  Patients with irradiated, burn or ischaemic wounds

          -  Patients with a BMI &gt;35

          -  Patients deemed to require a staged procedure, with hospital discharge occurring
             between procedures

          -  Patients deemed to require biological dressings / skin substitutes

          -  Patients for whom wound healing by secondary intention is deemed necessary

          -  Patients who have been treated with systemic immunosuppressants (including
             corticosteroids), or cytotoxic chemotherapy in the last 30 days, or who are
             anticipated to require such medications during the course of the study

          -  Patients known to have Acquired Immunodeficiency Syndrome (AIDS) or known to be
             infected with Human Immunodeficiency Virus (HIV)

          -  Patients with a known history of poor compliance with medical treatment

          -  Patients who have participated in this evaluation previously or who are currently
             participating in another clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert D Galiano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University Feinberg School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern University Feinberg School of Medicine</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Attinger CE, Janis JE, Steinberg J, Schwartz J, Al-Attar A, Couch K. Clinical approach to wounds: débridement and wound bed preparation including the use of dressings and wound-healing adjuvants. Plast Reconstr Surg. 2006 Jun;117(7 Suppl):72S-109S. Review.</citation>
    <PMID>16799376</PMID>
  </reference>
  <reference>
    <citation>Steed DL, Donohoe D, Webster MW, Lindsley L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg. 1996 Jul;183(1):61-4.</citation>
    <PMID>8673309</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2010</study_first_submitted>
  <study_first_submitted_qc>January 14, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2010</study_first_posted>
  <results_first_submitted>June 12, 2012</results_first_submitted>
  <results_first_submitted_qc>September 7, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 8, 2012</results_first_posted>
  <last_update_submitted>February 12, 2018</last_update_submitted>
  <last_update_submitted_qc>February 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>VERSAJET hydro-surgical debridement</keyword>
  <keyword>traumatic wound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
    <mesh_term>Surgical Wound Dehiscence</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>VERSAJET</title>
          <description>Excision with VERSAJET™ Hydrosurgery System</description>
        </group>
        <group group_id="P2">
          <title>Conventional Therapy</title>
          <description>Conventional operating room excision will consist of sharp instrumentation and electrocautery techniques, with the use of pulse lavage at the investigator's discretion. The type of sharp instrumentation, together with the brand of pulse lavage will be recorded.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>VERSAJET</title>
          <description>Excision with VERSAJET™ Hydrosurgery System</description>
        </group>
        <group group_id="B2">
          <title>Conventional Therapy</title>
          <description>Conventional operating room excision will consist of sharp instrumentation and electrocautery techniques, with the use of pulse lavage at the investigator's discretion. The type of sharp instrumentation, together with the brand of pulse lavage will be recorded.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
            <count group_id="B2" value="19"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52.2" spread="15.5"/>
                    <measurement group_id="B2" value="57.1" spread="13.7"/>
                    <measurement group_id="B3" value="54.5" spread="14.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Difference in Time to Closure Between Wounds Surgically Excised With VERSAJET™ Hydrosurgery System and Those Surgically Excised Using Conventional Operating Room Techniques.</title>
        <time_frame>28 days plus 6 week follow-up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VERSAJET</title>
            <description>Excision with VERSAJET™ Hydrosurgery System</description>
          </group>
          <group group_id="O2">
            <title>Conventional Therapy</title>
            <description>Conventional operating room excision will consist of sharp instrumentation and electrocautery techniques, with the use of pulse lavage at the investigator's discretion. The type of sharp instrumentation, together with the brand of pulse lavage will be recorded.</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Time to Closure Between Wounds Surgically Excised With VERSAJET™ Hydrosurgery System and Those Surgically Excised Using Conventional Operating Room Techniques.</title>
          <units>Time (minutes)</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" spread="3.7"/>
                    <measurement group_id="O2" value="15" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time of Actual Excision Procedure</title>
        <time_frame>28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VERSAJET</title>
            <description>Excision with VERSAJET™ Hydrosurgery System</description>
          </group>
          <group group_id="O2">
            <title>Conventional Therapy</title>
            <description>Conventional operating room excision will consist of sharp instrumentation and electrocautery techniques, with the use of pulse lavage at the investigator's discretion. The type of sharp instrumentation, together with the brand of pulse lavage will be recorded.</description>
          </group>
        </group_list>
        <measure>
          <title>Time of Actual Excision Procedure</title>
          <units>Time (Minutes)</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" spread="3.7"/>
                    <measurement group_id="O2" value="15" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cost Per Operative Procedure</title>
        <time_frame>28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VERSAJET</title>
            <description>Excision with VERSAJET™ Hydrosurgery System</description>
          </group>
          <group group_id="O2">
            <title>Conventional Therapy</title>
            <description>Conventional operating room excision will consist of sharp instrumentation and electrocautery techniques, with the use of pulse lavage at the investigator's discretion. The type of sharp instrumentation, together with the brand of pulse lavage will be recorded.</description>
          </group>
        </group_list>
        <measure>
          <title>Cost Per Operative Procedure</title>
          <units>Dollars $</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4411.70" spread="2020.2"/>
                    <measurement group_id="O2" value="6014.10" spread="4143.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cost of Reference Wound-related Surgical Procedures to Achieve Closure</title>
        <time_frame>28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VERSAJET</title>
            <description>Excision with VERSAJET™ Hydrosurgery System</description>
          </group>
          <group group_id="O2">
            <title>Conventional Therapy</title>
            <description>Conventional operating room excision will consist of sharp instrumentation and electrocautery techniques, with the use of pulse lavage at the investigator's discretion. The type of sharp instrumentation, together with the brand of pulse lavage will be recorded.</description>
          </group>
        </group_list>
        <measure>
          <title>Cost of Reference Wound-related Surgical Procedures to Achieve Closure</title>
          <units>Dollars ($)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13689.1" spread="8154.3"/>
                    <measurement group_id="O2" value="12869.4" spread="5703.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quantitative Bacteriology From Standardised Tissue Biopsies Pre- /Post- 1st Excision &amp; Pre-closure</title>
        <time_frame>28 days</time_frame>
        <population>Pre and post-excision values added, (cfu/g) tissue.</population>
        <group_list>
          <group group_id="O1">
            <title>VERSAJET</title>
            <description>Excision with VERSAJET™ Hydrosurgery System</description>
          </group>
          <group group_id="O2">
            <title>Conventional Therapy</title>
            <description>Conventional operating room excision will consist of sharp instrumentation and electrocautery techniques, with the use of pulse lavage at the investigator's discretion. The type of sharp instrumentation, together with the brand of pulse lavage will be recorded.</description>
          </group>
        </group_list>
        <measure>
          <title>Quantitative Bacteriology From Standardised Tissue Biopsies Pre- /Post- 1st Excision &amp; Pre-closure</title>
          <population>Pre and post-excision values added, (cfu/g) tissue.</population>
          <units>cfu/g</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-first excision bacterial count (log10) cfu/g</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="2.1"/>
                    <measurement group_id="O2" value="4.0" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-first excision bacterial count (log10) cfu/g</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="2.0"/>
                    <measurement group_id="O2" value="3.3" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Patients Achieving Stable Closure Within Study Period</title>
        <time_frame>28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VERSAJET</title>
            <description>Excision with VERSAJET™ Hydrosurgery System</description>
          </group>
          <group group_id="O2">
            <title>Conventional Therapy</title>
            <description>Conventional operating room excision will consist of sharp instrumentation and electrocautery techniques, with the use of pulse lavage at the investigator's discretion. The type of sharp instrumentation, together with the brand of pulse lavage will be recorded.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients Achieving Stable Closure Within Study Period</title>
          <units>percentage of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.9"/>
                    <measurement group_id="O2" value="42.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospital Stay (1st Excision to Discharge (Days))</title>
        <time_frame>28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VERSAJET</title>
            <description>Excision with VERSAJET™ Hydrosurgery System</description>
          </group>
          <group group_id="O2">
            <title>Conventional Therapy</title>
            <description>Conventional operating room excision will consist of sharp instrumentation and electrocautery techniques, with the use of pulse lavage at the investigator's discretion. The type of sharp instrumentation, together with the brand of pulse lavage will be recorded.</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospital Stay (1st Excision to Discharge (Days))</title>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39" spread="22.6"/>
                    <measurement group_id="O2" value="38" spread="18.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patient's With Wound-related Readmissions</title>
        <time_frame>28 days and 6 week follow up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VERSAJET</title>
            <description>Excision with VERSAJET™ Hydrosurgery System</description>
          </group>
          <group group_id="O2">
            <title>Conventional Therapy</title>
            <description>Conventional operating room excision will consist of sharp instrumentation and electrocautery techniques, with the use of pulse lavage at the investigator's discretion. The type of sharp instrumentation, together with the brand of pulse lavage will be recorded.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patient's With Wound-related Readmissions</title>
          <units>Number of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patient's With Serious Adverse Events and Relationship to Device</title>
        <time_frame>28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VERSAJET</title>
            <description>Excision with VERSAJET™ Hydrosurgery System</description>
          </group>
          <group group_id="O2">
            <title>Conventional Therapy</title>
            <description>Conventional operating room excision will consist of sharp instrumentation and electrocautery techniques, with the use of pulse lavage at the investigator's discretion. The type of sharp instrumentation, together with the brand of pulse lavage will be recorded.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patient's With Serious Adverse Events and Relationship to Device</title>
          <units>Number of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>VERSAJET</title>
          <description>Excision with VERSAJET™ Hydrosurgery System</description>
        </group>
        <group group_id="E2">
          <title>Conventional Therapy</title>
          <description>Conventional operating room excision will consist of sharp instrumentation and electrocautery techniques, with the use of pulse lavage at the investigator's discretion. The type of sharp instrumentation, together with the brand of pulse lavage will be recorded.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>small bowel obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>calcaneal pin site infection leading to foot gangrene</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>infection leading to prolonged hospitalisation and an amputation of the distal portion of the right</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>sacral pressure sore</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>flap dehiscence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>flap failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>seroma leading to limited flap dehiscence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>partial flap failure/dehiscence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Robert D Galiano, Assistant Professor of Surgery</name_or_title>
      <organization>Northwestern Medical Faculty Foundation</organization>
      <phone>312-695-6022</phone>
      <email>rgaliano@nmh.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

